Clement Named WBBA Chairman

Luke Timmerman9/16/08

Tom Clement, the CEO of Pathway Medical, has been named the new chairman of the Washington Biotechnology and Biomedical Association. He’s been busy lately at his day job, since Pathway, a Kirkland, WA-based maker of medical devices to clear fatty buildups in leg arteries, won FDA approval of its first device. Clement’s term with the WBBA last two years. He takes over for Jim Gore of the Pacific Northwest Diabetes Research Center.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.